Loading MHRA search...
Drug Safety Update
Volume 5, Issue 7 February 2012
Latest advice for medicines users
Welcome to the latest issue of Drug Safety Update.
February 2012 (Volume 5, Issue 7)
Drug Safety Update is essential reading for all healthcare professionals, bringing you the very latest information and advice to support the safer use of medicines.
Drug safety advice
-
Fingolimod (Gilenya▼): transient bradycardias and heart block after first dose—strengthened cardiovascular monitoring
Because of the risk of transient bradycardias and heart block after the first dose, the recommended level of cardiovascular monitoring of all patients after their first dose of fingolimod has now increased as outlined here -
Blue dyes: risk of serious allergic reactions
Blue dyes (eg Patent Blue V, isosulfan blue) used for imaging purposes during surgery are associated with the occurrence of serious allergic reactions, including anaphylaxis. Surgeons are reminded to have competent personnel and emergency facilities available for at least 1 hour after administration of the blue dye.
-
Looking for previous DSU publications?
Search by publication date above or view earlier publications in PDF
Report a safety problem
Visit our Yellow Card area to report a side effect with a medicine.
Page last modified:
10 February 2012
Head office: 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ
General enquiries: info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form